Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE (BUNDLE)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05993689 |
Recruitment Status :
Not yet recruiting
First Posted : August 15, 2023
Last Update Posted : May 29, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Pregnancy Related | Other: BUNDLE Other: Usual Care | Not Applicable |
The BUNDLE study is a prospective mixed-methods study focused on the early integration of community doula into prenatal care. The investigators will pursue the following aims using a multidisciplinary team of experts in health disparities, community engagement, qualitative research, maternal-fetal medicine, and doula support:
Aim 1: Develop an integrated prenatal care model of medical providers and community doulas in Southeastern Wisconsin Approach: The investigators will conduct six focus groups with 30 Black/AA birthing people (currently pregnant or recently postpartum) and 30 prenatal healthcare providers (obstetricians, midwives, doulas, social workers, prenatal care coordinators, nurses, mental health providers, and obstetric unit leaders) to elicit feedback on models of doula/medical provider integration with the overarching aim of building trust and improving maternal health outcomes. Focus group findings will be reviewed with a community advisory panel (CAP) developed as part of the Community Partnership of the MCW U54 center, to gain the CAP's input on intervention development.
Aim 2: Compare the effectiveness of the integrated prenatal care model to standard prenatal care in improving healthcare engagement and trust and reducing adverse maternal outcomes Approach: In a two-arm randomized controlled trial conducted at Froedtert and MCW, the investigators will randomize 412 Black/AA pregnant people to BUNDLE or standard prenatal care. Primary outcome is healthcare engagement (starting prenatal care in 1st trimester, attending at least 70% of the recommended visits, attending the postpartum visit, and receipt of recommended vaccination during pregnancy). Secondary outcomes include medical mistrust measured by trust in provider scale, perceived discrimination, and frequencies of severe maternal morbidity as defined by the Centers for Disease Control.
Aim 3: Disseminate findings to scholarly and community-based forums and actively pursue opportunities for systems- and policy-level change Approach: The investigators will disseminate findings regularly in scholarly (conference, grand rounds) and community-based (listening session, town hall) forums. The investigators will leverage the existing partnerships with policymakers, healthcare organizations, and community leaders to implement strategies to sustain successful program outcomes through policy changes at the system and statewide level by advocating for doula coverage and healthcare system sustainability of the integrated prenatal care model.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 412 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE |
Estimated Study Start Date : | October 1, 2024 |
Estimated Primary Completion Date : | June 30, 2030 |
Estimated Study Completion Date : | June 30, 2030 |
Arm | Intervention/treatment |
---|---|
Experimental: BUNDLE Intervention
Proposed components of the intervention will include: 1) attendance at two visits in the 2nd trimester and two visits in the 3rd trimester by a doula; 2) exchange of contact information between the clinic and the doula; 3) exchange of social needs and social-structural risk factors complicating patient's prenatal care from doula and exchange of clinical risk factors complicating prenatal care from obstetric provider; 4) communication between the doula and provider; 5) educating the obstetric team on benefits of doula support; 6) preparing labor and delivery team for presence of doula during labor ; and 7) enhancing doula support postpartum for cardiovascular risk reduction.
|
Other: BUNDLE
An integrated model of community-based doulas and clinical obstetric providers |
Active Comparator: Usual Care
Standard of care for pregnancy and pregnancy-related issues will be provided by the obstetric provider as per routine.
|
Other: Usual Care
Standard of care for pregnancy and pregnancy-related issues by the obstetric provider |
- Perinatal Healthcare Engagement [ Time Frame: From study enrollment and until 12 months postpartum ]A composite of the following variables to assess perinatal healthcare engagement: 1) Attended at least ~75% of the recommended prenatal visits; 2) Attended postpartum visit; 3) Received recommended vaccination during pregnancy.
- Trust in Provider [ Time Frame: Baseline; third trimester, and postpartum ]A validated 11-item instrument used to measure patients' trust in the provider regarding dependability, confidence, and confidentiality of information.
- Reported Discrimination [ Time Frame: Baseline, third trimester and postpartum ]Measured with a validated survey of patient self-report on how often in the past 12 months, individuals felt treated poorly due to race.
- Perceived Stress [ Time Frame: Baseline, third trimester and postpartum ]Measured with Cohen's Perceived Stress Scale
- Depression [ Time Frame: Baseline, third trimester and postpartum ]Measured with the Patient Health Questionnaire-9 (PHQ-9)
- Cesarean birth [ Time Frame: At study completion ]Cesarean birth for any indication other than prior cesarean
- Unplanned healthcare utilization [ Time Frame: Up to 12 months postpartum ]Prenatal or postpartum (up to 12 weeks postpartum) unplanned emergency room visits or hospitalizations.
- Severe Maternal Morbidity [ Time Frame: Up to 12 months postpartum ]Composite outcome of the following diagnoses using ICD-10 codes: acute myocardial infarction, aneurysm, acute renal failure, adult respiratory distress syndrome, amniotic fluid embolism, cardiac arrest, disseminated intravascular coagulation, eclampsia, heart failure, puerperal cerebrovascular disorders, pulmonary edema, severe anesthesia complications, sepsis, shock, sickle cell disease with crisis, air and thrombotic embolism blood products transfusion, hysterectomy, temporary tracheostomy, ventilation.
- Breastfeeding Initiation [ Time Frame: Up to 12 months postpartum ]Rates of breastfeeding initiation prior to discharge from the hospital
- Group-Based Medical Mistrust Scale [ Time Frame: Baseline; Week 27 up to birth (third trimester); Birth up to Week 40 (Postpartum) ]A 12-item validated survey focused on healthcare provided in the social context of racism and discrimination.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Self-reported Black or African American
- Pregnant with singleton gestation
- Has an established OBGY at Froedtert & the Medical College of Wisconsin (F&MCW) Health System
Exclusion Criteria:
- Planning to deliver outside of F&MCW Health System
- Receiving support beyond routing prenatal care, such as group prenatal care or has their own doula
- Inability or unwillingness to provide informed consent
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05993689
Contact: Anna Palatnik, MD | (414) 805-6624 | apalatnik@mcw.edu | |
Contact: Joni S Williams, MD, MPH | (414) 955-8827 | jswilliams@mcw.edu |
Responsible Party: | Anna Palatnik, MD, Associate Professor, Medical College of Wisconsin |
ClinicalTrials.gov Identifier: | NCT05993689 |
Other Study ID Numbers: |
PRO00047801 |
First Posted: | August 15, 2023 Key Record Dates |
Last Update Posted: | May 29, 2024 |
Last Verified: | May 2024 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |